• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 21 / 2013
        E.g., 1 / 21 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    Administration Names New FDA Commissioner

    March 23, 2009

    On March 14, 2009, the Obama administration announced that it had chosen Margaret A. Hamburg, a Harvard-educated physician and former New York City health commissioner, to be the new commissioner of the Food and Drug Administration (FDA). The Obama administration also chose Joshua Sharfstein, Baltimore’s health commissioner, to serve as Dr. Hamburg’s principal deputy commissioner. In announcing the appointments, President Obama noted that the laws and regulations governing food safety were out of date and in need of change.

    Dr. Hamburg is considered to be a nationally and internationally recognized leader in public health and medicine as well as an authority on global health, public health systems, infectious disease, bioterrorism and emergency preparedness. Her previous experience includes serving as the Nuclear Threat Initiative’s founding Vice President for the Biological Program. She also served as Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services. Further, Dr. Hamburg spent six years as Commissioner of Health for the City of New York. She also served as the Assistant Director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

    Dr. Joshua M. Sharfstein is Commissioner of Health for the City of Baltimore and serves as chair of the board of four affiliated nonprofit agencies. He has also been involved in efforts to protect children from unsafe jewelry and over-the-counter medication and ensuring Americans with disabilities have access to prescription drugs.

    The appointments of Drs. Hamburg and Sharfstein clearly signal that the new administration is intent on reforming FDA. The Obama administration can be expected to work closely with Commerce Committee Chair Henry Waxman (D-CA) and John Dingell (D-MI) to pass FDA reform legislation, which will then be implemented by Commissioner Hamburg.  

    For more information, please contact:

    Georgia Ravitz
    ravitz.georgia@arentfox.com
    202.857.8939

    James R. Ravitz
    ravitz.james@arentfox.com
    202.857.8903

    Amy S. Colvin
    colvin.amy@arentfox.com
    202.857.6338

    James H. Hartten
    hartten.james@arentfox.com
    202.857.8983

    Related People

    • James H. Hartten*
    • Georgia Ravitz
    • James R. Ravitz

    Related Practices

    FDA Practice (Food & Drug)
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.